![](/img/cover-not-exists.png)
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer
Suleiman Massarweh, Yee L. Tham, Jian Huang, Krystal Sexton, Heidi Weiss, Anna Tsimelzon, Amanda Beyer, Mothaffar Rimawi, Wei Yen Cai, Susan Hilsenbeck, Suzanne Fuqua, Richard ElledgeVolume:
129
Language:
english
Pages:
9
DOI:
10.1007/s10549-011-1679-8
Date:
October, 2011
File:
PDF, 361 KB
english, 2011